Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aavantgarde Bio Srl

Clinical trials sponsored by Aavantgarde Bio Srl, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New study tracks stargardt disease to pave way for future treatments Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

Gene therapy injection aims to save sight in rare eye disease

Disease control Recruiting now

This study tests a gene therapy called AAVB-039 for Stargardt disease, an inherited condition that causes vision loss. About 75 adults with a specific gene mutation will receive a single injection under the retina. The main goal is to check safety, but researchers will also measu…

Phase 1/2 • Sponsor: AAVantgarde Bio Srl • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC